# Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075

> **NCT03248947** · EARLY_PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 71 (actual)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** buprenorphine/naloxone
- **OTHER:** Pharmacist-administered buprenorphine/naloxone maintenance care

## Key facts

- **NCT ID:** NCT03248947
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-28
- **Primary completion:** 2019-06-27
- **Final completion:** 2019-06-27
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2021-07-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03248947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03248947, "Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03248947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*